ArticleTranslational oncology2026

The pseudouridine epitranscriptomic landscape of advanced prostate cancer therapeutic resistance identifies TIMM17A as a key player.

Shu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.